Drug Name Review

Watch Video


Before any drug reaches the market, its name is thoroughly examined to identify misleading or potentially confusing names. FDA Drug Info Rounds pharmacists discuss FDA’s responsibility for reviewing and approving new product names. The screening process for proposed proprietary drug names is reviewed, and the role of the Division of Medication Error Prevention and Analysis (DMEPA) and Office of Prescription Drug Promotion (OPDP) are explained.

Page Last Updated: 03/03/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English